Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Exousia Bio (LMMY) Revenue (2023 - 2024)

Lamy (LMMY) has disclosed Revenue for 2 consecutive years, with $3750.0 as the latest value for Q3 2024.

  • Quarterly Revenue changed N/A to $3750.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $3750.0 through May 2025, down 67.39% year-over-year, with the annual reading at $3750.0 for FY2025, 67.39% down from the prior year.
  • Revenue hit $3750.0 in Q3 2024 for Lamy, roughly flat from $3750.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3875.0 in Q4 2023 to a low of $3750.0 in Q2 2024.